Ricerca offers a spectrum of services for the areas of agrochemical registration, environmental analysis and preclinical discovery and development for biopharmaceutical registration.
Ricerca holds a current DEA license to handle multiple kilos of agency-controlled Schedule II-V substances for research and development projects at its Concord, Ohio, facility. This would include preparation of Phase I to Phase II clinical bulk API supplies.
Rich Donaldson, vice president of chemical development at Ricerca, said: “We have the ability to move forward on clients’ R&D projects that require a DEA license with no delay.